ArticleUpdates in surgery2025
Intrahepatic ductoplasty effectively corrects the ductal dilatation in Todani type IV-A choledochal cyst in children.
Article in Updates in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Predictive value of cyst size for clinical symptoms in patients with prenatally diagnosed choledochal cysts.Translational pediatrics · 2026Article
- Surgical management strategies and postoperative outcomes of choledochal cysts in children: the role of preoperative radiological assessment in a retrospective observational study.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Primary ductal stricture and intrahepatic duct dilatation are characteristic features in Todani type IV-A choledochal cysts (CDC) and necessitate thorough evaluation and management during surgical treatment. This study aimed to present our experience with ductoplasties for type IV-A CDCs with primary ductal strictures. Between June 2015 and June 2022, 54 patients were reviewed. Primary ductal strictures were identified, and ductoplasties were performed individually. The demographic characteristics, imaging examinations, postoperative outcomes, and complications were evaluated. Among enrolled patients, 36 (66.66%) had strictures at the exit of the common hepatic duct (CHD), 13 (24.07%) had strictures at the exit of the left hepatic duct (LHD) and/or right hepatic duct (RHD), 4 (7.41%) had strictures at the exit of the CHD, with LHD and/or RHD, and 1 (1.85%) patient had strictures at the level 2 or more intrahepatic biliary duct. The median follow-up period was 5.20 years. The dilated intrahepatic ducts returning to a normal size occurred in 52 (96.30%) patients. Two (3.70%) patients experienced anastomosis leakage and required surgical repair 3 ~ 5 days later. Liver function normalized within 1 year postoperatively. It is safe and effective to perform ductoplasties for primary ductal strictures in Todani type IV-A CDCs.
Indexed as
Identifiers
40048091What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.